Law­mak­ers ask FDA to out­line Covid-19 vac­cine ap­proval process

Key De­mo­c­ra­t­ic mem­bers in the US House of Rep­re­sen­ta­tives have called on FDA com­mis­sion­er Stephen Hahn to brief their staff on how the agency plans to make de­ci­sions re­gard­ing the de­vel­op­ment, re­view and de­ploy­ment of vac­cines against the nov­el coro­n­avirus SARS-CoV-2.

In a let­ter dat­ed June 18, Rep. Car­olyn Mal­oney (D-NY), chair­woman of the House Com­mit­tee on Over­sight and Re­form, Rep. Ra­ja Kr­ish­namoor­thi (D-IL), chair­man of the com­mit­tee’s Sub­com­mit­tee on Eco­nom­ic and Con­sumer Pol­i­cy, along with Rep. James Clyburn (D-SC), chair­man of the Se­lect Sub­com­mit­tee on the Coro­n­avirus Cri­sis, of­fered sug­ges­tions as to how Hahn could im­prove pub­lic con­fi­dence in any Covid-19 vac­cines his agency might au­tho­rize. They al­so in­vit­ed the com­mis­sion­er to brief their staff on the top­ic on Ju­ly 2.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER